Prediction of sustained response to low-dose pegylated interferon alpha-2b plus ribavirin in patients with genotype 1b and high hepatitis C virus level using viral reduction within 2 weeks after therapy initiation
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-12-01
著者
-
ICHINOSE Masao
Second Department of Internal Medicine, Wakayama Medical University
-
INOUE Izumi
Second Department of Internal Medicine, Wakayama Medical University
-
Ichinose Masao
Second Department Of Internal Medicine Wakayama Medical University
-
Ueda Kazuki
Second Department of Internal Medicine, Wakayama Medical University
-
Oka Masashi
Second Department Of Internal Medicine Wakayama Medical University
-
Tamai Hideyuki
Second Department Of Internal Medicine Wakayama Medical University
-
Inoue Izumi
Second Department Of Internal Medicine Wakayama Medical University
-
Shingaki Naoki
Second Department Of Internal Medicine Wakayama Medical University
-
Iguchi Mikitaka
Second Department Of Internal Medicine Wakayama Medical College
-
Enomoto Shotaro
Second Department Of Internal Medicine Wakayama Medical University
-
Yanaoka Kimihiko
Second Department Of Internal Medicine Wakayama Medical College
-
Deguchi Hisanobu
Second Department Of Internal Medicine Wakayama Medical University
-
Shiraki Tatsuya
Second Department Of Internal Medicine Wakayama Medical University
-
MORIBATA Kosaku
Second Department of Internal Medicine, Wakayama Medical University
-
TUKUDA Hiroshi
Second Department of Internal Medicine, Wakayama Medical University
-
MORI Yoshiyuki
Second Department of Internal Medicine, Wakayama Medical University
-
MAEKITA Takao
Second Department of Internal Medicine, Wakayama Medical University
関連論文
- Lack of association between CpG island methylator phenotype in human gastric cancers and methylation in their background non-cancerous gastric mucosae
- ENDOSCOPIC SUBMUCOSAL DISSECTION FOR ESOPHAGEAL SQUAMOUS CELL NEOPLASMS
- Developmentally regulated expression of matrix metalloproteinases during fetal rat colon morphogenesis
- Potent induction therapy with interferon and ribavirin combination therapy does not achieve a higher sustained virological response rate in chronic hepatitis C with genotype 1b and high hepatitis C virus RNA level
- Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography
- Endothelin-3 controls growth of colonic epithelial cells by mediating epithelial-mesenchymal interaction
- Seronegative Alpha-Fetoprotein-Producing Gastric Cancer : An Early Form of Aggressive Cancer
- Growth of fetal rat gastro-intestinal epithelial cells is region-specifically controlled by growth factors and substrata in primary culture
- Chronic Estrogen Supplementation Following Ovariectomy Improves the Emotional Stress-Induced Cardiovascular Responses by Indirect Action on the Nervous System and by Direct Action on the Heart
- Purification and Further Characterization of Enteropeptidase from Porcine Duodenum
- ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC CANCER USING THE TIP OF AN ELECTROSURGICAL SNARE (THIN TYPE)
- Proliferation, differentiation and morphogenesis of fetal rat glandular stomach transplanted under the kidney capsule of syngeneic hosts
- Upregulation of Heme Oxygenase-1 in an Animal Model of Takotsubo Cardiomyopathy
- Risk factors for knee osteoarthritis in Japanese men : a case-control study
- Helicobacter pylori infection reduces intraluminal nitric oxide in humans
- An open-label, single-arm study assessing the efficacy and safety of L-menthol sprayed onto the gastric mucosa during upper gastrointestinal endoscopy
- Serum Pepsinogen and Gastric Cancer Screening
- Nonparasitic Solitary Giant Hepatic Cyst Causing Obstructive Jaundice was Successfully Treated with Monoethanolamine Oleate
- Prediction of sustained response to low-dose pegylated interferon alpha-2b plus ribavirin in patients with genotype 1b and high hepatitis C virus level using viral reduction within 2 weeks after therapy initiation
- Clinical features and risk factors of extrahepatic seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma
- Low-dose pegylated interferon-alpha-2a monotherapy in elderly and/or cirrhotic patients infected with hepatitis C virus genotype-2 or genotype-1 low level infection